Expansion & Global Reach MyTomorrows operates globally with offices in Amsterdam, New York City, and India, serving patients, physicians, and bio-pharma partners across multiple regions. This suggests sales opportunities with multinational pharma companies and CROs seeking expanded access and trial recruitment capabilities in diverse markets.

AI-Driven Platform The company has recently launched an AI-enhanced Expanded Access SaaS platform and is investing in an AI-driven global platform. This positions myTomorrows as a technologically advanced partner for pharma brands aiming to scale pre-approval access programs, real-world data collection, and streamlined access workflows.

Funding Momentum With substantial funding rounds totaling around $51 million and recent growth equity investments, there is evident investor confidence and potential budget availability for capacity expansion, product development, and enterprise contracts with larger pharma accounts.

Clinical Access Expertise MyTomorrows specializes in pre-approval access, clinical trial recruitment, international expanded access management, distribution, and quality / regulatory logistics, offering a comprehensive service suite for biotech and pharma sponsors seeking end-to-end access programs.

Proven Impact & Reach Having helped over 14,000 patients, 2,200 physicians, and 200 sites worldwide demonstrates traction and credibility. This track record can be leveraged to upsell to current sponsors and attract new partners looking for proven reach and patient navigation capabilities.